The Molecular Biology Society of Japan

[3P-0339] Invention of compounds with specific growth inhibitory activity against T-cell acute lymphoblastic leukemia-derived cells

○Yuki Fujita1,2, Tomoya Higashi1,2, Yoshihumi Hachiro1,2, Chihiro Yoshida1,2, Chihiro Nakata3,4, Takuya Yagi3,4, Azusa Takechi3,5, Nobuo Kitada1,2, Rika Obata1,2, Takahiko Hara3,4,5, Shojiro Maki1,2 (1. Dept. of Info. Sci., Grad. Sch., Univ. of Electro-Communications, 2. Center for Neuro Sci. and BioMed. Eng., Univ. of Electro-Communications, 3.Stem Cell Project., Tokyo Metropolitan Institute of Medical Science, 4.Dept. of Med. and Dent., Univ. of Tokyo Medical and Dental, 5.Dept. of Stem Cell reg., Univ. of Tokyo Metropolitan)

The 43rd Annual Meeting of the Molecular Biology Society of Japan

[3P-0341] Targeting all transforming growth factor-β isoforms with a novel Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer

○Hitomi Takahashi1, Kazuki Takahashi1, Yuichi Akatsu2,3, Katarzyna A. Podyma-Inoue1, Takehisa Matsumoto4, Yasuhiro Yoshimatsu1,5, Daizo Koinuma2, Mikako Shirouzu4, Kohei Miyazono2, Tetsuro Watabe1 (1.Dept. Biochem., Grad. Sch. Med. Dent., Tokyo Med. & Dent. Univ., 2.Dept. Mol. Pathol., Grad. Sch Med., Tokyo Univ., 3.Pharmaceutical Research Laboratories, Nippon Kayaku, 4.RIKEN, Biosystems Dynamic Research, 5.Div. Pharmacol., Grad. Sch. Med. Dent., Nigata Univ.)

The 43rd Annual Meeting of the Molecular Biology Society of Japan

[3P-0342] The gastrointestinal microbiota and clinical characteristics in patients with advanced solid tumor -SCRUM-Japan MONSTAR-SCREEN project-

○KENTARO SAWADA1, Riu Yamashita2, Satoshi Horasawa3, Shigenori Kadowaki4, Ken Kato5, Makoto Ueno6, Eiji Oki7, Naoki Takahashi8, Taro Sato9, Taito Esaki10, Daisuke Aoki11, Kazuhiro Yoshida12, Yoshiaki Nakamura3,13, Hiroya Taniguchi3,13, Takayuki Yoshino13 (1.Department of Oncology, Kushiro Rosai Hospital, Kushiro, 2.Translational Informatics, National Cancer Center Hospital East, 3.Translational Research Support Section, National Cancer Center Hospital East, 4.Department of Clinical Oncology, Aichi Cancer Center, 5.Department of Head and Neck Medical Oncology, National Cancer Center Hospital, 6.Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, 7.Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 8.Department of Gastroenterology, Saitama Cancer Center, 9.Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, 10.Gastrointestinal and Medical Oncology Division, National Hospital Organization Kyushu Cancer Center, 11.Department of Obstetrics & Gynecology, Keio University Hospital, 12.Department of Surgical Oncology, Gifu University Hospital, 13.Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East)

The 43rd Annual Meeting of the Molecular Biology Society of Japan